Core Insights - Lear (LEA) has a strong track record of beating earnings estimates, particularly in the last two quarters with an average surprise of 15.85% [1][5] - The most recent earnings report showed a surprise of 18.18%, with actual earnings of $2.64 per share compared to an expected $3.12 per share [2] - The previous quarter also saw a positive surprise of 13.51%, with actual earnings of $2.94 per share against an estimate of $2.59 per share [2] Earnings Estimates and Predictions - Estimates for Lear have been trending higher, supported by its history of earnings surprises [5] - The stock has a positive Zacks Earnings ESP of +5.50%, indicating bullish sentiment among analysts regarding its earnings prospects [8] - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) suggests a high likelihood of another earnings beat [8] Statistical Insights - Research indicates that stocks with a positive Earnings ESP and a Zacks Rank of 3 or better have a nearly 70% chance of producing a positive surprise [6] - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, reflecting the latest analyst revisions [7] - The next earnings report for Lear is expected to be released on July 25, 2025 [8]

Core Viewpoint - Invesco (IVZ) is positioned well to potentially beat earnings estimates in its upcoming quarterly report, supported by a solid history of exceeding expectations [1][6]. Earnings Performance - Invesco has a strong track record of surpassing earnings estimates, with an average surprise of 9.47% over the last two quarters [2]. - For the most recent quarter, Invesco reported earnings of $0.39 per share against an expectation of $0.44, resulting in a surprise of 12.82%. In the previous quarter, it reported $0.52 per share against a consensus estimate of $0.49, yielding a surprise of 6.12% [3]. Earnings Estimates and Predictions - Recent estimates for Invesco have been trending upward, with a positive Earnings ESP (Expected Surprise Prediction) indicating a strong likelihood of an earnings beat [6][9]. - The current Earnings ESP for Invesco stands at +1.65%, reflecting increased analyst optimism regarding its near-term earnings potential [9]. Zacks Rank and Success Rate - The combination of a positive Earnings ESP and a Zacks Rank of 1 (Strong Buy) suggests a high probability of another earnings beat, as stocks with this combination have a nearly 70% success rate in exceeding consensus estimates [7][9].

Core Viewpoint - Lennox International (LII) is positioned well to potentially beat earnings estimates in its upcoming quarterly report, supported by a strong history of exceeding expectations [1]. Group 1: Earnings Performance - Lennox has a solid track record of surpassing earnings estimates, with an average surprise of 18.04% over the last two quarters [2]. - In the last reported quarter, Lennox achieved earnings of $3.37 per share, exceeding the Zacks Consensus Estimate of $3.25 per share by 3.69% [3]. - For the previous quarter, the company reported earnings of $5.6 per share against an expectation of $4.23 per share, resulting in a surprise of 32.39% [3]. Group 2: Earnings Estimates and Predictions - Estimates for Lennox have been trending upward, aided by its history of earnings surprises, and the stock currently has a positive Zacks Earnings ESP of +2.03% [5][7]. - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) suggests a high likelihood of another earnings beat, with historical data indicating that nearly 70% of stocks with this combination exceed consensus estimates [6][7]. Group 3: Earnings Release Information - The next earnings report for Lennox is expected to be released on July 23, 2025 [7].

Group 1 - Manhattan Associates (MANH) is positioned to maintain its earnings-beat streak, particularly in the upcoming report, with a history of beating earnings estimates [1][5] - The company reported earnings of $1.02 per share for the most recent quarter, which was a surprise of 16.67% compared to the expected $1.19 per share [2] - In the previous quarter, Manhattan Associates exceeded the consensus estimate of $1.06 per share by reporting $1.17 per share, resulting in a surprise of 10.38% [2] Group 2 - Earnings estimates for Manhattan Associates have been trending higher, supported by its earnings surprise history [5] - The stock has a positive Zacks Earnings ESP of +1.07%, indicating bullish sentiment among analysts regarding its near-term earnings potential [8] - The next earnings report for Manhattan Associates is anticipated to be released on July 22, 2025 [8] Group 3 - Stocks with a positive Earnings ESP and a Zacks Rank of 3 (Hold) or better have a nearly 70% chance of producing a positive surprise [6] - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, reflecting the latest analyst revisions [7] - A negative Earnings ESP does not necessarily indicate an earnings miss, but it reduces predictive power [9]

Core Viewpoint - Moelis (MC) is positioned well to potentially beat earnings estimates in its upcoming quarterly report, supported by a strong history of earnings surprises [1][5]. Earnings Performance - In the most recent quarter, Moelis reported earnings of $0.57 per share, falling short of the expected $0.64 per share, resulting in a surprise of 12.28% [2]. - In the previous quarter, Moelis significantly exceeded expectations, reporting $1.18 per share against a consensus estimate of $0.46 per share, leading to a surprise of 156.52% [2]. Earnings Estimates and Predictions - There has been a favorable change in earnings estimates for Moelis, with a positive Zacks Earnings ESP (Expected Surprise Prediction) indicating a strong likelihood of an earnings beat [5][8]. - The current Earnings ESP for Moelis stands at +1.82%, suggesting analysts are optimistic about its near-term earnings potential [8]. Zacks Rank and Success Rate - Moelis holds a Zacks Rank of 3 (Hold), which, when combined with a positive Earnings ESP, historically results in a positive surprise rate of nearly 70% [6][8]. - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions [7].

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Labcorp Holdings (LH) , which belongs to the Zacks Medical Services industry, could be a great candidate to consider.This medical laboratory operator has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 2.21%.For the last reported quarter, Labcorp c ...

Core Insights - Molina Healthcare, Inc. (MOH) is scheduled to report its second-quarter 2025 results on July 23, 2025, with earnings estimated at $5.56 per share and revenues at $10.84 billion [1][2] Financial Performance - The second-quarter earnings estimate has seen three downward revisions recently, indicating a year-over-year decrease of 5.1% in earnings, while revenues are expected to grow by 9.7% year-over-year [2] - For the full year 2025, the revenue estimate stands at $44.06 billion, reflecting an 8.4% increase year-over-year, but the earnings per share estimate is $22.58, showing a slight decline of 0.3% [5] - Molina Healthcare has beaten consensus estimates in three of the last four quarters, with an average surprise of negative 1.6% [5] Membership and Premiums - The Zacks Consensus Estimate for premiums indicates a growth of 10.1% year-over-year in Q2, with Medicaid premiums expected to grow by 4.1% [7] - Medicaid membership is projected to decrease by 1.2% year-over-year, while Medicare membership is expected to grow by 4.2% [9] - Marketplace membership is anticipated to surge by 63% compared to the previous year [9] Cost and Income Trends - The medical care ratio (MCR) for the Marketplace is expected to rise to 77.49%, up from 71.60% a year ago, while the total MCR is projected at 88.86%, slightly up from 88.60% [9] - Rising costs and lower investment income are contributing to uncertainty regarding an earnings beat, with investment income expected to decline by 12.1% year-over-year [10] - Total operating expenses are predicted to increase by more than 8% from the previous year due to higher medical care costs and general administrative expenses [10] Market Position - The company currently holds a Zacks Rank of 5 (Strong Sell) and an Earnings ESP of -1.09%, indicating a lower likelihood of an earnings beat this quarter [6]

Core Insights - Danaher Corporation (DHR) is set to release its second-quarter 2025 results on July 22, before market open [1] Revenue Estimates - The Zacks Consensus Estimate for revenues is $5.84 billion, reflecting a 1.6% increase from the same quarter last year [2] - The consensus estimate for earnings is $1.64 per share, indicating a 4.7% decrease from the year-ago quarter [2] Segment Performance - The Life Sciences segment is expected to see a revenue decline of 3.4% to $1.71 billion due to weak demand in protein consumables, flow cytometry, and lab automation solutions [3] - The Biotechnology segment is projected to grow by 7% to $1.83 billion, driven by increased demand for bioprocessing consumables from large pharmaceutical customers [5] - The Diagnostics segment is anticipated to increase by 1.1% to $2.29 billion, supported by solid momentum in pathology and acute care diagnostics [6] Cost and Expenses - SG&A expenses are expected to rise by 5.8% to $1.55 billion, which may negatively impact the bottom line [4] - Foreign currency headwinds are likely to affect profitability due to significant international operations [4] Recent Developments - Danaher acquired Abcam plc in December 2023, enhancing its Life Sciences segment with a strong product portfolio and innovation capabilities [7] Earnings Prediction - The Earnings ESP for DHR is 0.00%, indicating no clear prediction for an earnings beat this quarter [9] - The company currently holds a Zacks Rank of 4 (Sell) [11]

Core Insights - NVR, Inc. is anticipated to report lower earnings and homebuilding revenues in Q2 2025 due to soft demand, high inventories, and margin pressures [1][10] Financial Performance - The Zacks Consensus Estimate for NVR's Q2 EPS has decreased to $106.33, reflecting an 11.9% decline from the previous year's EPS of $120.69 [3] - Revenue estimates for the quarter are set at $2.40 billion, indicating a 5.8% decrease from the year-ago figure of $2.55 billion [3][10] - In the last reported quarter, NVR's earnings and homebuilding revenues missed the Zacks Consensus Estimate by 12.1% and 1%, respectively [1] Market Conditions - The homebuilding industry is experiencing ongoing softness, with the spring 2025 selling season underperforming due to affordability issues and weakened consumer confidence [4] - High and fluctuating mortgage rates, along with economic uncertainties, have negatively impacted homebuyer activity during the peak sales period [4] Revenue and Settlement Predictions - Homebuilding revenues are expected to decline by 5.6% year-over-year to $2.4 billion, with the average selling price of settlements projected to decrease by 1.5% to $443,500 [5] - Total settlements are anticipated to drop by 4.2% to 5,422 units year-over-year [5] Cost and Margin Outlook - The company's gross margin for homebuilding is expected to decrease to 22.1%, down 150 basis points from the previous year [6][10] - Selling, general, and administrative expenses are projected to rise by 2.7% year-over-year for the homebuilding segment [6][10] Order and Backlog Trends - Total new orders are predicted to increase by 3.6% year-over-year to 6,287 units, while the backlog is expected to decline to 11,030 units from 11,597 units reported a year ago [7] - The value of the backlog is estimated to be $5.3 billion, down from $5.45 billion in the same quarter last year [7] Earnings Prediction Model - The current model does not predict an earnings beat for NVR, as it lacks the necessary combination of a positive Earnings ESP and a favorable Zacks Rank [8] - NVR has an Earnings ESP of +3.25% [9]

Core Viewpoint Teledyne Technologies is expected to report strong second-quarter 2025 results, with revenue and earnings growth driven by improved sales across all business segments, including Digital Imaging, Instrumentation, Aerospace & Defense Electronics, and Engineered Systems [1][6][7]. Group 1: Revenue Expectations - Teledyne Technologies is projected to post second-quarter revenue of $1.47 billion, reflecting a year-over-year increase of 7.1% [8]. - The Digital Imaging segment's revenues are estimated at $756.5 million, indicating a year-over-year growth of 2.3% [2]. - The Instrumentation segment is expected to generate revenues of $358.5 million, representing a year-over-year rise of 7.5% [3]. - The Aerospace & Defense Electronics unit's revenues are projected at $240.9 million, implying a significant growth of 23.9% compared to the previous year [4]. - Engineered Systems' revenues are estimated at $110.2 million, showing a rise of 3.2% from the year-ago quarter [5]. Group 2: Earnings Expectations - The consensus estimate for second-quarter earnings per share (EPS) is pegged at $5.01, indicating a growth of 9.4% from the prior-year figure [8]. - Positive synergies from the acquisitions of Micropac and Qioptiq are expected to contribute favorably to Teledyne's earnings performance [6][7]. Group 3: Market Position and Predictions - Teledyne Technologies has delivered a four-quarter earnings surprise of 2.69% on average, suggesting a history of exceeding earnings expectations [1]. - The company currently holds a Zacks Rank of 4 (Sell), indicating a less favorable outlook compared to peers [10]. - The Earnings ESP for Teledyne is +1.22%, but the model does not predict a definitive earnings beat this time [9].